These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7495602)

  • 1. Ethnic intermarriage and its consequences for cystic fibrosis carrier screening.
    Gilbert F; Schoelkopf J; Li Z; Arzimanoglou II; Shaham M; Udey J; Arzimanoglou I
    Am J Prev Med; 1995; 11(4):251-5. PubMed ID: 7495602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis.
    Arch Intern Med; 1999 Jul; 159(14):1529-39. PubMed ID: 10421275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis screening.
    Shulman LP
    J Midwifery Womens Health; 2005; 50(3):205-10. PubMed ID: 15894998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A universal array-based multiplexed test for cystic fibrosis carrier screening.
    Amos JA; Bridge-Cook P; Ponek V; Jarvis MR
    Expert Rev Mol Diagn; 2006 Jan; 6(1):15-22. PubMed ID: 16359263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the potential success of cystic fibrosis carrier screening: lessons learned from Tay-Sachs disease and beta-thalassemia.
    Laberge AM; Watts C; Porter K; Burke W
    Public Health Genomics; 2010; 13(5):310-9. PubMed ID: 19864874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to molecular cystic fibrosis testing.
    Uphoff TS; Highsmith WE
    Clin Lab Sci; 2006; 19(1):24-31. PubMed ID: 16617555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based carrier screening and prenatal diagnosis.
    Strom CM
    MLO Med Lab Obs; 2004 Aug; 36(8):12-7; quiz 20-1. PubMed ID: 15366363
    [No Abstract]   [Full Text] [Related]  

  • 8. Benchmarks for cystic fibrosis carrier screening: a European consensus document.
    Castellani C; Macek M; Cassiman JJ; Duff A; Massie J; ten Kate LP; Barton D; Cutting G; Dallapiccola B; Dequeker E; Girodon E; Grody W; Highsmith EW; Kääriäinen H; Kruip S; Morris M; Pignatti PF; Pypops U; Schwarz M; Soller M; Stuhrman M; Cuppens H
    J Cyst Fibros; 2010 May; 9(3):165-78. PubMed ID: 20363197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From new screens to discovered genes: the successful past and promising present of single gene disorders.
    Roe AM; Shur N
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):77-86. PubMed ID: 17315238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of prenatal carrier screening for cystic fibrosis.
    Lieu TA; Watson SE; Washington AE
    Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes of physicians and genetics professionals toward cystic fibrosis carrier screening.
    Faden RR; Tambor ES; Chase GA; Geller G; Hofman KJ; Holtzman NA
    Am J Med Genet; 1994 Mar; 50(1):1-11. PubMed ID: 8160745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis screening strategies.
    Cuckle H
    Br J Hosp Med; 1993 Oct 6-19; 50(7):398-402. PubMed ID: 8261285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preconception and prenatal screening for cystic fibrosis.
    Baskin LB; Wians FH; Elder F
    MLO Med Lab Obs; 2002 Oct; 34(10):8-12; quiz 14, 16. PubMed ID: 12385171
    [No Abstract]   [Full Text] [Related]  

  • 14. Cystic fibrosis carrier screening practices in an ethnically diverse region: experience of the Genetic Network of the Empire State, Puerto Rico, and the U.S. Virgin Islands.
    Schwind EL; Wolfe M; Greendale K; Misra LM; Pass KA; Wallerstein R
    Genet Test; 1999; 3(2):215-8. PubMed ID: 10464670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics and cystic fibrosis: a focus on carrier testing.
    Williams JK
    Pediatr Nurs; 1995; 21(5):444-8. PubMed ID: 8684846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.
    Struewing JP; Abeliovich D; Peretz T; Avishai N; Kaback MM; Collins FS; Brody LC
    Nat Genet; 1995 Oct; 11(2):198-200. PubMed ID: 7550349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis screening in assisted reproduction.
    Gazvani R; Lewis-Jones I
    Curr Opin Obstet Gynecol; 2006 Jun; 18(3):268-72. PubMed ID: 16735825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for cystic fibrosis carrier state.
    Mennuti MT; Thomson E; Press N
    Obstet Gynecol; 1999 Mar; 93(3):456-61. PubMed ID: 10075000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CFTR mutations in patients from Colombia: implications for local and regional molecular diagnosis programs.
    Keyeux G; Rodas C; Bienvenu T; Garavito P; Vidaud D; Sanchez D; Kaplan JC; Aristizábal G
    Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.